foxo4-dri senolytic peptide Development of a novel senolytic

Because it is a chronic condition, people living with Crohns are likely to be on lifelong medication

BPC-157 is not for human consumption as sold (research use), is not FDA-approved, and is WADA-prohibited

Package Weight: 50g Package size: 5 x 5 cm x 4 cm (manual measurements, deviations of 1-3 mm are possible

Potential Side Effects BPC-157 remains one of the best-tolerated healing peptides, though minor side effects may include: Temporary injection site irritation Rare headaches or lightheadedness Appetite changes (uncommon) Rare reports of transient fatigue No major systemic toxicity or hormonal disruptions have been reported in current research literature

Dosing calculations: Determine daily dose based on protocol (typically 200-500mcg BPC-157, 2-5mg TB-500 twice weekly)

This treatment is well suited for men committed to longevity, improved performance, and sustained wellness